Q2 2022 13F Holders as of 30 Jun 2022
-
Type / Class
-
Equity / COM
-
Number of holders
-
96
-
Total 13F shares, excl. options
-
63,013,354
-
Shares change
-
-1,800,629
-
Total reported value, excl. options
-
$185,887,462
-
Value change
-
-$5,592,533
-
Put/Call ratio
-
41%
-
Number of buys
-
47
-
Number of sells
-
-53
-
Price
-
$2.95
Significant Holders of CYMABAY THERAPEUTICS INC - COM (CBAY) as of Q2 2022
126 filings reported holding CBAY - CYMABAY THERAPEUTICS INC - COM as of Q2 2022.
CYMABAY THERAPEUTICS INC - COM (CBAY) has 96 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 63,013,354 shares
.
Largest 10 shareholders include Avoro Capital Advisors LLC (10,300,000 shares), TCG Crossover Management, LLC (5,905,400 shares), COMMODORE CAPITAL LP (5,738,500 shares), VANGUARD GROUP INC (3,557,042 shares), MILLENNIUM MANAGEMENT LLC (3,015,496 shares), Nantahala Capital Management, LLC (2,644,306 shares), Lynx1 Capital Management LP (2,589,679 shares), BAKER BROS. ADVISORS LP (2,170,464 shares), BlackRock Inc. (1,952,869 shares), and DAFNA Capital Management LLC (1,787,569 shares).
This table shows the top 96 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.